News

Los Angeles, CA –  February 6, 2025 - The Terasaki Institute for Biomedical Engineering (TIBI) is pleased to announce their selection of Dr. Liangfang Zhang - Irwin Jacobs Chancellor’s Endowed Chair Professor at the University of California San Diego, and Dr. Aydogan Ozcan – Chancellor’s Professor, UCLA & Professor, Howard Hughes Medical Institute (HHMI), as the recipients of the inaugural  Keith Terasaki Mid-Career Innovation Award. These awards will be presented at the 3rd Annual Terasaki Innovation Summit, to be held March 5-7, 2025, at the Terasaki Institute Research Headquarters in Woodland Hills, California.

Read more ...

Los Angeles, CA – February 5th, 2025 -  The Terasaki Institute for Biomedical Engineering (TIBI) is pleased to announce their selection of Dr. Cato Laurencin, Chief Executive Officer, Connecticut Convergence Institute, Professor, University of Connecticut as the recipient of the 2025 Paul Terasaki  Innovation Award and Dr Jun Chen, Associate Professor, Department of Bioengineering, University of California, Los Angeles (UCLA), as the recipient of the 2025 Hisako Terasaki Young Innovator Award.  These awards will be presented at the 3rd Annual Terasaki Innovation Summit, to be held March 5-7, 2025, at the Terasaki Institute Research Headquarters in Woodland Hills, California.

Read more ...

Los Angeles, CA – January 27, 2025 - Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, according to a new study published in Advanced Functional Materials. The breakthrough centers on a new class of materials called lipopeptide hydrogels (LPHs), which show promise in boosting immune responses and possess adjuvant-like properties.

Read more ...

Los Angeles, CA – January 24, 2025 -  The Terasaki Institute for Biomedical Innovation- in Los Angeles and the Technology Innovation Institute (TII), the dedicated research arm of Abu Dhabi’s Advanced Technology Research Council (ATRC), have started a new collaboration to advance drug discovery and disease modeling related to neurological conditions.

Read more ...

(LOS ANGELES)  —  It is with a heavy heart that the Terasaki Institute announces the passing of our beloved Chairman of the Board, Dr. Keith Terasaki. Dr. Keith passed away peacefully on the morning of Sunday, December 22, 2024, after a courageous battle with a rare form of lymphoma. His loss is deeply felt by all who had the privilege of knowing him.

Read more ...

 (LOS ANGELES)  —  The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to welcome five new members to its Leadership Board. The TIBI Leadership Board comprises notable visionary individuals who utilize their expertise to promote key initiatives and provide valuable guidance on the institute's research and innovation strategies.

Read more ...

(LOS ANGELES)  — The Terasaki Institute for Biomedical Innovation (TIBI) concludes an extraordinary year of scientific discovery and technological innovation that promises to transform healthcare across multiple critical domains. Under the leadership of CEO Dr. Ali Khademhosseini, the institute has made significant strides in bioengineering, regenerative medicine, and personalized healthcare technologies.

Read more ...

 (LOS ANGELES)  —  Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary injectable granular filler that could transform the way diabetic wounds are treated, potentially improving patient outcomes. The groundbreaking study, published in ACS Nano, introduced an innovative approach about using specialized porous dermal fillers that accelerate tissue healing and regeneration.

Read more ...